<SEC-DOCUMENT>0001193125-13-402831.txt : 20131018
<SEC-HEADER>0001193125-13-402831.hdr.sgml : 20131018
<ACCEPTANCE-DATETIME>20131017190342
ACCESSION NUMBER:		0001193125-13-402831
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20131016
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20131018
DATE AS OF CHANGE:		20131017

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MACROGENICS INC
		CENTRAL INDEX KEY:			0001125345
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36112
		FILM NUMBER:		131157941

	BUSINESS ADDRESS:	
		STREET 1:		9640 MEDICAL CENTER DRIVE
		CITY:			Rockville
		STATE:			MD
		ZIP:			20850
		BUSINESS PHONE:		301-251-5172

	MAIL ADDRESS:	
		STREET 1:		9640 MEDICAL CENTER DRIVE
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d613759d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>WASHINGTON, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM 8-K
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant
to Section&nbsp;13 or 15(d) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>of the Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported):&nbsp;October 16, 2013 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>MACROGENICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact Name of Registrant as Specified in its Charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>DELAWARE</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>001-36112</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>06-1591613</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction&nbsp;of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>incorporation or organization)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(IRS Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>9640 Medical Center Drive </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Rockville, Maryland </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive offices) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>20850 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Zip Code)
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(301) 251-5172 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Registrant&#146;s telephone number, including area code) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Not Applicable </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Former
name or former address, if changed since last report) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </TD></TR></TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;16, 2013, MacroGenics, Inc. (the &#147;Company&#148;) filed an amended and restated certificate of incorporation (the
&#147;Restated Certificate&#148;) with the Secretary of State of the State of Delaware in connection with closing of the initial public offering (the &#147;IPO&#148;) of shares of its common stock. The Company&#146;s board of directors and
stockholders previously approved the Restated Certificate to be filed in connection with, and to be effective upon, the closing of the IPO. On October 17, 2013, the Company filed a Certificate of Correction with the Secretary of State of the State
of Delaware to correct a clerical error in the Restated Certificate. The Certificate of Correction replaced the first sentence of Article FOURTH of the Restated Certificate in order to correct the par value of each of the authorized Common Stock and
Preferred Stock to be $0.01 per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Restated Certificate amends and restates the Company&#146;s certificate of incorporation in
its entirety to, among other things: (i)&nbsp;reduce the authorized number of shares of common stock from 425,000,000 shares to 125,000,000 shares; (ii)&nbsp;eliminate all references to the previously existing series of preferred stock;
(iii)&nbsp;authorize 5,000,000 shares of undesignated preferred stock that may be issued from time to time by the Company&#146;s board of directors in one or more series; (iv)&nbsp;establish a classified board of directors, divided into three
classes, each of whose members will serve for staggered three-year terms; (v)&nbsp;provide that directors may be removed from office only for cause and only upon the affirmative vote of the holders of at least 75% of the votes that all of the
Company&#146;s stockholders would be entitled to cast in an annual election of directors; (vi)&nbsp;provide that any vacancy on our board of directors, including a vacancy resulting from an enlargement of our board of directors, may be filled only
by vote of a majority of our directors then in office; and (vii)&nbsp;eliminate the ability of the Company&#146;s stockholders to take action by written consent in lieu of a meeting and call special meetings of stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of October&nbsp;17, 2013, the Company has issued and outstanding 25,020,288 shares of common stock and 3,151,226 shares of common stock
reserved for issuance upon exercise of outstanding employee stock options. No shares of preferred stock are outstanding as of such date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing description of the Restated Certificate is qualified by reference to the Restated Certificate, a copy of which is attached
hereto as Exhibit 3.1 and is incorporated herein by reference. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, upon the closing of the IPO, amended and restated by-laws of
the Company (the &#147;Amended and Restated By-Laws&#148;), previously approved by the Company&#146;s board of directors and stockholders, became effective. The Amended and Restated By-Laws, among other things: (i)&nbsp;eliminate the ability of the
Company&#146;s stockholders to take action by written consent in lieu of a meeting and call special meetings of stockholders; (ii)&nbsp;establish procedures relating to the presentation of stockholder proposals at stockholder meetings;
(iii)&nbsp;establish procedures relating to the nomination of directors; and (iv)&nbsp;conform to the amended provisions of the Restated Certificate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing description of the amendments made in the Amended and Restated By-Laws is qualified by reference to the Amended and Restated
By-Laws, a copy of </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
which was filed as Exhibit 3.4 to Amendment No.&nbsp;2 to the Registration Statement on Form S-1 (File No.&nbsp;333-190994) by the Company on October&nbsp;1, 2013 and is incorporated herein by
reference. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;8.01 Other Events. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;16, 2013, the Company completed its initial public offering of 5,750,000 shares of its common stock at a price to the public of
$16.00 per share, which includes the exercise in full by the underwriters of the offering of their option to purchase 750,000 additional shares of the Company&#146;s common stock. The Company also issued a press release on October&nbsp;16, 2013
announcing the closing of the initial public offering, a copy of which is being filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;9.01. Financial Statements and Exhibits. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Exhibits </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The exhibits to
this current report are listed in the Exhibit Index attached hereto and incorporated by reference herein. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">MACROGENICS, INC.</TD></TR>
<TR>
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Scott Koenig</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">Scott Koenig, M.D., Ph.D.</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">President and Chief Executive Officer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Date:&nbsp;October 17, 2013 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Exhibit</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; width:23.50pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">No.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:37.25pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Description</P></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;3.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Restated Certificate of Incorporation of MacroGenics, Inc.</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;3.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Amended and Restated By-Laws of MacroGenics, Inc. (incorporated by reference to Exhibit 3.4 to Amendment No. 2 to the Registration Statement on Form S-1 (File No. 333-190994) filed by the Registrant on October 1, 2013).</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;3.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Certificate of Correction to the Restated Certificate of Incorporation of MacroGenics, Inc.</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press release, dated October 16, 2013, announcing the completion of MacroGenics, Inc.&#146;s initial public offering.</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>d613759dex31.htm
<DESCRIPTION>EX-3.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-3.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 3.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RESTATED CERTIFICATE OF INCORPORATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MACROGENICS, INC.
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MacroGenics, Inc. (the &#147;Corporation&#148;), a corporation organized and existing under the General Corporation Law of the State
of Delaware (the &#147;DGCL&#148;), does hereby certify that: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The name of the Corporation is MacroGenics, Inc. The original Certificate
of Incorporation of the Corporation was filed with the Secretary of State of the State of Delaware on August&nbsp;14, 2000, was amended and restated on September&nbsp;15, 2000, was further amended on December&nbsp;4, 2000, was further amended and
restated on June&nbsp;6, 2002, was further amended on October&nbsp;23, 2003, was further amended and restated on October&nbsp;12, 2004, was further amended and restated on June&nbsp;30, 2005, was further amended and restated on May&nbsp;15, 2006,
was further amended and restated on July&nbsp;15, 2008, was further amended and restated on September&nbsp;19, 2008, was further amended on January&nbsp;14, 2011, and was further amended on September&nbsp;26, 2013. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A resolution was duly adopted by the Board of Directors of the Corporation pursuant to Sections 242 and 245 of the DGCL proposing this
Restated Certificate of Incorporation and declaring the advisability of this Restated Certificate of Incorporation. The stockholders of the Corporation duly approved and adopted this Restated Certificate of Incorporation by written consent in
accordance with Sections 228, 242 and 245 of the DGCL. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Accordingly, the Certificate of Incorporation of this Corporation, as previously
amended and restated, is hereby further amended and restated in its entirety to read as follows. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">FIRST: The name of the Corporation is
MacroGenics, Inc. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECOND: The address of the Corporation&#146;s registered office in the State of Delaware is Corporation Trust Center,
1209&nbsp;Orange Street, in the City of Wilmington, County of New&nbsp;Castle, 19801. The name of its registered agent at that address is The Corporation Trust Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">THIRD: The nature of the business or purposes to be conducted or promoted by the Corporation is to engage in any lawful act or activity for
which corporations may be organized under the General Corporation Law of the State of Delaware. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">FOURTH: The total number of shares of all
classes of stock which the Corporation shall have authority to issue is 130,000,000 shares, consisting of (i)&nbsp;125,000,000 shares of Common Stock, $.0001 par value per share (&#147;Common Stock&#148;), and (ii)&nbsp;5,000,000 shares of Preferred
Stock, $.0001 par value per share (&#147;Preferred Stock&#148;). </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a statement of the designations and the powers, privileges and rights, and the
qualifications, limitations or restrictions thereof in respect of each class of capital stock of the Corporation. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"><U>COMMON STOCK</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">1. <U>General</U>. The voting, dividend and liquidation rights of the
holders of the Common Stock are subject to and qualified by the rights of the holders of the Preferred Stock of any series as may be designated by the Board of Directors of the Corporation (the &#147;Board of Directors&#148;) upon any issuance of
the Preferred Stock of any series. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">2. <U>Voting</U>. The holders of the Common Stock shall have voting rights at all meetings of
stockholders, each such holder being entitled to one vote for each share thereof held by such holder; <U>provided</U>, <U>however</U>, that, except as otherwise required by law, holders of Common Stock shall not be entitled to vote on any amendment
to this Certificate of Incorporation (which, as used herein, shall mean the certificate of incorporation of the Corporation, as amended from time to time, including the terms of any certificate of designations of any series of Preferred Stock) that
relates solely to the terms of one or more outstanding series of Preferred Stock if the holders of such affected series are entitled, either separately or together as a class with the holders of one or more other such series, to vote thereon
pursuant to this Certificate of Incorporation. There shall be no cumulative voting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The number of authorized shares of Common Stock may
be increased or decreased (but not below the number of shares thereof then outstanding) by the affirmative vote of the holders of a majority of the stock of the Corporation entitled to vote, irrespective of the provisions of Section&nbsp;242(b)(2)
of the General Corporation Law of the State of Delaware. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">3. <U>Dividends</U>. Dividends may be declared and paid on the Common Stock from
funds lawfully available therefor as and when determined by the Board of Directors and subject to any preferential dividend or other rights of any then outstanding Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">4. <U>Liquidation</U>. Upon the dissolution or liquidation of the Corporation, whether voluntary or involuntary, holders of Common Stock will
be entitled to receive all assets of the Corporation available for distribution to its stockholders, subject to any preferential or other rights of any then outstanding Preferred Stock. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">B.</TD>
<TD ALIGN="left" VALIGN="top"><U>PREFERRED STOCK</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Preferred Stock may be issued from time to time in one or more series,
each of such series to have such terms as stated or expressed herein and in the resolution or resolutions providing for the issue of such series adopted by the Board of Directors as hereinafter provided. Any shares of Preferred Stock which may be
redeemed, purchased or acquired by the Corporation may be reissued except as otherwise provided by law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Authority is hereby expressly
granted to the Board of Directors from time to time to issue the Preferred Stock in one or more series, and in connection with the creation of any such series, by adopting a resolution or resolutions providing for the issuance of the shares thereof
and by filing a certificate of designations relating thereto in accordance with the General Corporation Law of the State of Delaware, to determine and fix the number of shares of such series and such
</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
voting powers, full or limited, or no voting powers, and such designations, preferences and relative participating, optional or other special rights, and qualifications, limitations or
restrictions thereof, including without limitation thereof, dividend rights, conversion rights, redemption privileges and liquidation preferences, as shall be stated and expressed in such resolutions, all to the full extent now or hereafter
permitted by the General Corporation Law of the State of Delaware. Without limiting the generality of the foregoing, the resolutions providing for issuance of any series of Preferred Stock may provide that such series shall be superior or rank
equally or be junior to any other series of Preferred Stock to the extent permitted by law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The number of authorized shares of Preferred
Stock may be increased or decreased (but not below the number of shares then outstanding) by the affirmative vote of the holders of a majority of the voting power of the capital stock of the Corporation entitled to vote thereon, voting as a single
class, irrespective of the provisions of Section&nbsp;242(b)(2) of the General Corporation Law of the State of Delaware. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">FIFTH: Except as
otherwise provided herein, the Corporation reserves the right to amend, alter, change or repeal any provision contained in this Certificate of Incorporation, in the manner now or hereafter prescribed by statute and this Certificate of Incorporation,
and all rights conferred upon stockholders herein are granted subject to this reservation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SIXTH: In furtherance and not in limitation of
the powers conferred upon it by the General Corporation Law of the State of Delaware, and subject to the terms of any series of Preferred Stock, the Board of Directors shall have the power to adopt, amend, alter or repeal the By-laws of the
Corporation by the affirmative vote of a majority of the directors present at any regular or special meeting of the Board of Directors at which a quorum is present. The stockholders may not adopt, amend, alter or repeal the By-laws of the
Corporation, or adopt any provision inconsistent therewith, unless such action is approved, in addition to any other vote required by this Certificate of Incorporation, by the affirmative vote of the holders of at least seventy-five percent
(75%)&nbsp;of the votes that all the stockholders would be entitled to cast in any annual election of directors or class of directors. Notwithstanding any other provisions of law, this Certificate of Incorporation or the By-laws of the Corporation,
and notwithstanding the fact that a lesser percentage may be specified by law, the affirmative vote of the holders of at least seventy-five percent (75%)&nbsp;of the votes which all the stockholders would be entitled to cast in any annual election
of directors or class of directors shall be required to amend or repeal, or to adopt any provision inconsistent with, this Article&nbsp;SIXTH. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SEVENTH: Except to the extent that the General Corporation Law of the State of Delaware prohibits the elimination or limitation of liability
of directors for breaches of fiduciary duty, no director of the Corporation shall be personally liable to the Corporation or its stockholders for monetary damages for any breach of fiduciary duty as a director, notwithstanding any provision of law
imposing such liability. No amendment to or repeal of this provision shall apply to or have any effect on the liability or alleged liability of any director of the Corporation for or with respect to any acts or omissions of such director occurring
prior to such amendment or repeal. If the General Corporation Law of the State of Delaware is amended to permit further elimination or limitation of the personal liability of directors, then the liability of a director of the Corporation shall be
eliminated or limited to the fullest extent permitted by the General Corporation Law of the State of Delaware as so amended. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">EIGHTH: The Corporation shall provide indemnification as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Actions, Suits and Proceedings Other than by or in the Right of the Corporation</U>. The Corporation shall indemnify each person who was
or is a party or threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the Corporation) by reason of the
fact that he or she is or was, or has agreed to become, a director or officer of the Corporation, or is or was serving, or has agreed to serve, at the request of the Corporation, as a director, officer, partner, employee or trustee of, or in a
similar capacity with, another corporation, partnership, joint venture, trust or other enterprise (including any employee benefit plan) (all such persons being referred to hereafter as an &#147;Indemnitee&#148;), or by reason of any action alleged
to have been taken or omitted in such capacity, against all expenses (including attorneys&#146; fees), liabilities, losses, judgments, fines (including excise taxes and penalties arising under the Employee Retirement Income Security Act of 1974),
and amounts paid in settlement actually and reasonably incurred by or on behalf of Indemnitee in connection with such action, suit or proceeding and any appeal therefrom, if Indemnitee acted in good faith and in a manner which Indemnitee reasonably
believed to be in, or not opposed to, the best interests of the Corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful. The Corporation may, by action of its Board of
Directors, and to the extent provided in such action, indemnify employees and other persons as though they were Indemnitees. The rights to indemnification as provided in this Article Eighth shall be non-exclusive of any other rights that any person
may have or hereafter acquire under an statute, provision of this Certificate of Incorporation, the Corporation&#146;s Bylaws, agreement, vote of stockholders or Directors, or otherwise. The termination of any action, suit or proceeding by judgment,
order, settlement, conviction or upon a plea of <U>nolo</U> <U>contendere</U> or its equivalent, shall not, of itself, create a presumption that Indemnitee did not act in good faith and in a manner which Indemnitee reasonably believed to be in, or
not opposed to, the best interests of the Corporation, and, with respect to any criminal action or proceeding, had reasonable cause to believe that his or her conduct was unlawful. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Actions or Suits by or in the Right of the Corporation</U>. The Corporation shall indemnify any Indemnitee who was or is a party to or
threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the Corporation to procure a judgment in its favor by reason of the fact that Indemnitee is or was, or has agreed to become, a director or
officer of the Corporation, or is or was serving, or has agreed to serve, at the request of the Corporation, as a director, officer, partner, employee or trustee of, or in a similar capacity with, another corporation, partnership, joint venture,
trust or other enterprise (including any employee benefit plan), or by reason of any action alleged to have been taken or omitted in such capacity, against all expenses (including attorneys&#146; fees) and, to the extent permitted by law, amounts
paid in settlement actually and reasonably incurred by or on behalf of Indemnitee in connection with such action, suit or proceeding and any appeal therefrom, if Indemnitee acted in good faith and in a manner which Indemnitee reasonably believed to
be in, or not opposed to, the best interests of the Corporation, except that no indemnification shall be made under this </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Section&nbsp;2 in respect of any claim, issue or matter as to which Indemnitee shall have been adjudged to be liable to the Corporation, unless, and only to the extent, that the Court of Chancery
of Delaware or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of such liability but in view of all the circumstances of the case, Indemnitee is fairly and reasonably entitled to
indemnity for such expenses (including attorneys&#146; fees) which the Court of Chancery of Delaware or such other court shall deem proper. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Indemnification for Expenses of Successful Party</U>. Notwithstanding any other provisions of this Article EIGHTH, to the extent that an
Indemnitee has been successful, on the merits or otherwise, in defense of any action, suit or proceeding referred to in Sections&nbsp;1 and 2 of this Article EIGHTH, or in defense of any claim, issue or matter therein, or on appeal from any such
action, suit or proceeding, Indemnitee shall be indemnified against all expenses (including attorneys&#146; fees) actually and reasonably incurred by or on behalf of Indemnitee in connection therewith. Without limiting the foregoing, if any action,
suit or proceeding is disposed of, on the merits or otherwise (including a disposition without prejudice), without (i)&nbsp;the disposition being adverse to Indemnitee, (ii)&nbsp;an adjudication that Indemnitee was liable to the Corporation,
(iii)&nbsp;a plea of guilty or <U>nolo</U> <U>contendere</U> by Indemnitee, (iv)&nbsp;an adjudication that Indemnitee did not act in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the
Corporation, and (v)&nbsp;with respect to any criminal proceeding, an adjudication that Indemnitee had reasonable cause to believe his or her conduct was unlawful, Indemnitee shall be considered for the purposes hereof to have been wholly successful
with respect thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Notification and Defense of Claim</U>. As a condition precedent to an Indemnitee&#146;s right to be
indemnified, such Indemnitee must notify the Corporation in writing as soon as practicable of any action, suit, proceeding or investigation involving such Indemnitee for which indemnity will or could be sought. With respect to any action, suit,
proceeding or investigation of which the Corporation is so notified, the Corporation will be entitled to participate therein at its own expense and/or to assume the defense thereof at its own expense, with legal counsel reasonably acceptable to
Indemnitee. After notice from the Corporation to Indemnitee of its election so to assume such defense, the Corporation shall not be liable to Indemnitee for any legal or other expenses subsequently incurred by Indemnitee in connection with such
action, suit, proceeding or investigation, other than as provided below in this Section&nbsp;4. Indemnitee shall have the right to employ his or her own counsel in connection with such action, suit, proceeding or investigation, but the fees and
expenses of such counsel incurred after notice from the Corporation of its assumption of the defense thereof shall be at the expense of Indemnitee unless (i)&nbsp;the employment of counsel by Indemnitee has been authorized by the Corporation,
(ii)&nbsp;counsel to Indemnitee shall have reasonably concluded that there may be a conflict of interest or position on any significant issue between the Corporation and Indemnitee in the conduct of the defense of such action, suit, proceeding or
investigation or (iii)&nbsp;the Corporation shall not in fact have employed counsel to assume the defense of such action, suit, proceeding or investigation, in each of which cases the fees and expenses of counsel for Indemnitee shall be at the
expense of the Corporation, except as otherwise expressly provided by this Article EIGHTH. The Corporation shall not be entitled, without the consent of Indemnitee, to assume the defense of any claim brought by or in the right of the Corporation or
as to which counsel for Indemnitee shall have reasonably made the conclusion provided for in clause&nbsp;(ii) above. The Corporation shall not be required to indemnify Indemnitee under this Article EIGHTH for any amounts paid in settlement
</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of any action, suit, proceeding or investigation effected without its written consent. The Corporation shall not settle any action, suit, proceeding or investigation in any manner which would
impose any penalty or limitation on Indemnitee without Indemnitee&#146;s written consent. Neither the Corporation nor Indemnitee will unreasonably withhold or delay its consent to any proposed settlement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Advance of Expenses</U>. Subject to the provisions of Section&nbsp;6 of this Article EIGHTH, in the event of any threatened or pending
action, suit, proceeding or investigation of which the Corporation receives notice under this Article EIGHTH, any expenses (including attorneys&#146; fees) incurred by or on behalf of an Indemnitee in defending an action, suit, proceeding or
investigation or any appeal therefrom shall be paid by the Corporation in advance of the final disposition of such matter; <U>provided</U>, <U>however</U>, that the payment of such expenses incurred by or on behalf of Indemnitee in advance of the
final disposition of such matter shall be made only upon receipt of an undertaking by or on behalf of Indemnitee to repay all amounts so advanced in the event that it shall ultimately be determined by final judicial decision from which there is no
further right to appeal that Indemnitee is not entitled to be indemnified by the Corporation as authorized in this Article EIGHTH; and <U>provided</U> <U>further</U> that no such advancement of expenses shall be made under this Article EIGHTH if it
is determined (in the manner described in Section&nbsp;6) that (i)&nbsp;Indemnitee did not act in good faith and in a manner he or she reasonably believed to be in, or not opposed to, the best interests of the Corporation, or (ii)&nbsp;with respect
to any criminal action or proceeding, Indemnitee had reasonable cause to believe his or her conduct was unlawful. Such undertaking shall be accepted without reference to the financial ability of Indemnitee to make such repayment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Procedure for Indemnification and Advancement of Expenses</U>. In order to obtain indemnification or advancement of expenses pursuant to
Section&nbsp;1, 2, 3 or 5 of this Article EIGHTH, an Indemnitee shall submit to the Corporation a written request. Any such advancement of expenses shall be made promptly, and in any event within 60&nbsp;days after receipt by the Corporation of the
written request of Indemnitee, unless (i)&nbsp;the Corporation has assumed the defense pursuant to Section&nbsp;4 of this Article EIGHTH (and none of the circumstances described in Section&nbsp;4 of this Article EIGHTH that would nonetheless entitle
the Indemnitee to indemnification for the fees and expenses of separate counsel have occurred) or (ii)&nbsp;the Corporation determines within such 60-day period that Indemnitee did not meet the applicable standard of conduct set forth in
Section&nbsp;1, 2 or 5 of this Article EIGHTH, as the case may be. Any such indemnification, unless ordered by a court, shall be made with respect to requests under Section&nbsp;1 or 2 only as authorized in the specific case upon a determination by
the Corporation that the indemnification of Indemnitee is proper because Indemnitee has met the applicable standard of conduct set forth in Section&nbsp;1 or 2, as the case may be. Such determination shall be made in each instance (a)&nbsp;by a
majority vote of the directors of the Corporation consisting of persons who are not at that time parties to the action, suit or proceeding in question (&#147;disinterested directors&#148;), whether or not a quorum, (b)&nbsp;by a committee of
disinterested directors designated by majority vote of disinterested directors, whether or not a quorum, (c)&nbsp;if there are no disinterested directors, or if the disinterested directors so direct, by independent legal counsel (who may, to the
extent permitted by law, be regular legal counsel to the Corporation) in a written opinion, or (d)&nbsp;by the stockholders of the Corporation. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Remedies</U>. The right to indemnification or advancement of expenses as granted by this
Article EIGHTH shall be enforceable by Indemnitee in any court of competent jurisdiction. Neither the failure of the Corporation to have made a determination prior to the commencement of such action that indemnification is proper in the
circumstances because Indemnitee has met the applicable standard of conduct, nor an actual determination by the Corporation pursuant to Section&nbsp;6 of this Article EIGHTH that Indemnitee has not met such applicable standard of conduct, shall be a
defense to the action or create a presumption that Indemnitee has not met the applicable standard of conduct. In any suit brought by Indemnitee to enforce a right to indemnification, or brought by the Corporation to recover an advancement of
expenses pursuant to the terms of an undertaking, the Corporation shall have the burden of proving that Indemnitee is not entitled to be indemnified, or to such advancement of expenses, under this Article EIGHTH. Indemnitee&#146;s expenses
(including attorneys&#146; fees) reasonably incurred in connection with successfully establishing Indemnitee&#146;s right to indemnification, in whole or in part, in any such proceeding shall also be indemnified by the Corporation. Notwithstanding
the foregoing, in any suit brought by Indemnitee to enforce a right to indemnification hereunder it shall be a defense that the Indemnitee has not met any applicable standard for indemnification set forth in the General Corporation Law of the State
of Delaware. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>Limitations</U>. Notwithstanding anything to the contrary in this Article EIGHTH, except as set forth in
Section&nbsp;7 of this Article EIGHTH, the Corporation shall not indemnify an Indemnitee pursuant to this Article EIGHTH in connection with a proceeding (or part thereof) initiated by such Indemnitee unless the initiation thereof was approved by the
Board of Directors. Notwithstanding anything to the contrary in this Article EIGHTH, the Corporation shall not indemnify an Indemnitee to the extent such Indemnitee is reimbursed from the proceeds of insurance, and in the event the Corporation makes
any indemnification payments to an Indemnitee and such Indemnitee is subsequently reimbursed from the proceeds of insurance, such Indemnitee shall promptly refund indemnification payments to the Corporation to the extent of such insurance
reimbursement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>Subsequent Amendment</U>. No amendment, termination or repeal of this Article EIGHTH or of the relevant provisions
of the General Corporation Law of the State of Delaware or any other applicable laws shall adversely affect or diminish in any way the rights of any Indemnitee to indemnification under the provisions hereof with respect to any action, suit,
proceeding or investigation arising out of or relating to any actions, transactions or facts occurring prior to the final adoption of such amendment, termination or repeal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>Other Rights</U>. The indemnification and advancement of expenses provided by this Article EIGHTH shall not be deemed exclusive of any
other rights to which an Indemnitee seeking indemnification or advancement of expenses may be entitled under any law (common or statutory), agreement or vote of stockholders or disinterested directors or otherwise, both as to action in
Indemnitee&#146;s official capacity and as to action in any other capacity while holding office for the Corporation, and shall continue as to an Indemnitee who has ceased to be a director or officer, and shall inure to the benefit of the estate,
heirs, executors and administrators of Indemnitee. Nothing contained in this Article EIGHTH shall be deemed to prohibit, and the Corporation is specifically authorized to enter into, agreements with officers and directors providing indemnification
rights and procedures different from those set forth in this Article </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
EIGHTH. In addition, the Corporation may, to the extent authorized from time to time by its Board of Directors, grant indemnification rights to other employees or agents of the Corporation or
other persons serving the Corporation and such rights may be equivalent to, or greater or less than, those set forth in this Article EIGHTH. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <U>Partial Indemnification</U>. If an Indemnitee is entitled under any provision of this Article EIGHTH to indemnification by the
Corporation for some or a portion of the expenses (including attorneys&#146; fees), liabilities, losses, judgments, fines (including excise taxes and penalties arising under the Employee Retirement Income Security Act of 1974) or amounts paid in
settlement actually and reasonably incurred by or on behalf of Indemnitee in connection with any action, suit, proceeding or investigation and any appeal therefrom but not, however, for the total amount thereof, the Corporation shall nevertheless
indemnify Indemnitee for the portion of such expenses (including attorneys&#146; fees), liabilities, losses, judgments, fines (including excise taxes and penalties arising under the Employee Retirement Income Security Act of 1974) or amounts paid in
settlement to which Indemnitee is entitled. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <U>Insurance</U>. The Corporation may purchase and maintain insurance, at its expense, to
protect itself and any director, officer, employee or agent of the Corporation or another corporation, partnership, joint venture, trust or other enterprise (including any employee benefit plan) against any expense, liability or loss incurred by him
or her in any such capacity, or arising out of his or her status as such, whether or not the Corporation would have the power to indemnify such person against such expense, liability or loss under the General Corporation Law of the State of
Delaware. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <U>Savings Clause</U>. If this Article EIGHTH or any portion hereof shall be invalidated on any ground by any court of
competent jurisdiction, then the Corporation shall nevertheless indemnify each Indemnitee as to any expenses (including attorneys&#146; fees), liabilities, losses, judgments, fines (including excise taxes and penalties arising under the Employee
Retirement Income Security Act of 1974) and amounts paid in settlement in connection with any action, suit, proceeding or investigation, whether civil, criminal or administrative, including an action by or in the right of the Corporation, to the
fullest extent permitted by any applicable portion of this Article EIGHTH that shall not have been invalidated and to the fullest extent permitted by applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <U>Definitions</U>. Terms used herein and defined in Section&nbsp;145(h) and Section&nbsp;145(i) of the General Corporation Law of the
State of Delaware shall have the respective meanings assigned to such terms in such Section&nbsp;145(h) and Section&nbsp;145(i). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NINTH:
This Article NINTH is inserted for the management of the business and for the conduct of the affairs of the Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>General
Powers</U>. The business and affairs of the Corporation shall be managed by or under the direction of the Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.
<U>Number of Directors; Election of Directors</U>. Subject to the rights of holders of any series of Preferred Stock to elect directors, the number of directors of the Corporation shall be established by the Board of Directors. Election of directors
need not be by written ballot, except as and to the extent provided in the By-laws of the Corporation. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Classes of Directors</U>. Subject to the rights of holders of any series of Preferred Stock
to elect directors, the Board of Directors shall be and is divided into three classes, designated Class I, Class II and Class III. Each class shall consist, as nearly as may be possible, of one-third of the total number of directors constituting the
entire Board of Directors. The Board of Directors is authorized to assign members of the Board of Directors already in office to Class I, Class II or Class III at the time such classification becomes effective. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Terms of Office</U>. Subject to the rights of holders of any series of Preferred Stock to elect directors, each director shall serve for
a term ending on the date of the third annual meeting of stockholders following the annual meeting of stockholders at which such director was elected; <U>provided</U> that each director initially assigned to Class&nbsp;I shall serve for a term
expiring at the Corporation&#146;s first annual meeting of stockholders held after the effectiveness of this Restated Certificate of Incorporation; each director initially assigned to Class&nbsp;II shall serve for a term expiring at the
Corporation&#146;s second annual meeting of stockholders held after the effectiveness of this Restated Certificate of Incorporation; and each director initially assigned to Class&nbsp;III shall serve for a term expiring at the Corporation&#146;s
third annual meeting of stockholders held after the effectiveness of this Restated Certificate of Incorporation; <U>provided</U> <U>further</U>, that the term of each director shall continue until the election and qualification of his or her
successor and be subject to his or her earlier death, resignation or removal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Quorum</U>. The greater of (a)&nbsp;a majority of the
directors at any time in office and (b)&nbsp;one-third of the number of directors fixed pursuant to Section&nbsp;2 of this Article NINTH shall constitute a quorum of the Board of Directors. If at any meeting of the Board of Directors there shall be
less than such a quorum, a majority of the directors present may adjourn the meeting from time to time without further notice other than announcement at the meeting, until a quorum shall be present. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Action at Meeting</U>. Every act or decision done or made by a majority of the directors present at a meeting duly held at which a
quorum is present shall be regarded as the act of the Board of Directors unless a greater number is required by law or by this Certificate of Incorporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Removal</U>. Subject to the rights of holders of any series of Preferred Stock, directors of the Corporation may be removed only for
cause and only by the affirmative vote of the holders of at least seventy-five percent (75%)&nbsp;of the votes which all the stockholders would be entitled to cast in any annual election of directors or class of directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>Vacancies</U>. Subject to the rights of holders of any series of Preferred Stock, any vacancy or newly created directorship in the Board
of Directors, however occurring, shall be filled only by vote of a majority of the directors then in office, although less than a quorum, or by a sole remaining director and shall not be filled by the stockholders. A director elected to fill a
vacancy shall hold office until the next election of the class for which such director shall have been chosen, subject to the election and qualification of a successor and to such director&#146;s earlier death, resignation or removal. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>Stockholder Nominations and Introduction of Business, Etc</U>. Advance notice of
stockholder nominations for election of directors and other business to be brought by stockholders before a meeting of stockholders shall be given in the manner provided by the By-laws of the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>Amendments to Article</U>. Notwithstanding any other provisions of law, this Certificate of Incorporation or the By-laws of the
Corporation, and notwithstanding the fact that a lesser percentage may be specified by law, the affirmative vote of the holders of at least seventy-five percent (75%)&nbsp;of the votes which all the stockholders would be entitled to cast in any
annual election of directors or class of directors shall be required to amend or repeal, or to adopt any provision inconsistent with, this Article&nbsp;NINTH. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">TENTH: Stockholders of the Corporation may not take any action by written consent in lieu of a meeting. Notwithstanding any other provisions
of law, this Certificate of Incorporation or the By-laws of the Corporation, and notwithstanding the fact that a lesser percentage may be specified by law, the affirmative vote of the holders of at least seventy-five percent (75%)&nbsp;of the votes
which all the stockholders would be entitled to cast in any annual election of directors or class of directors shall be required to amend or repeal, or to adopt any provision inconsistent with, this Article TENTH. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ELEVENTH: Special meetings of stockholders for any purpose or purposes may be called at any time by only the Board of Directors, the Chairman
of the Board of Directors or the Chief Executive Officer of the Corporation, and may not be called by any other person or persons. Business transacted at any special meeting of stockholders shall be limited to matters relating to the purpose or
purposes stated in the notice of meeting. Notwithstanding any other provisions of law, this Certificate of Incorporation or the By-laws of the Corporation, and notwithstanding the fact that a lesser percentage may be specified by law, the
affirmative vote of the holders of at least seventy-five percent (75%)&nbsp;of the votes which all the stockholders would be entitled to cast in any annual election of directors or class of directors shall be required to amend or repeal, or to adopt
any provision inconsistent with, this Article&nbsp;ELEVENTH. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, this Restated Certificate of Incorporation, which
restates, integrates and amends the certificate of incorporation of the Corporation, and which has been duly adopted in accordance with Sections 228, 242 and 245 of the General Corporation Law of the State of Delaware, has been executed by its duly
authorized officer this 16<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> day of October&nbsp;, 2013. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">MACROGENICS, INC.</TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Scott Koenig</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">Scott Koenig</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">President and Chief Executive Officer</TD></TR>
</TABLE></DIV>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.3
<SEQUENCE>3
<FILENAME>d613759dex33.htm
<DESCRIPTION>EX-3.3
<TEXT>
<HTML><HEAD>
<TITLE>EX-3.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 3.3 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATE OF CORRECTION OF </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED CERTIFICATE OF INCORPORATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF MACROGENICS, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MacroGenics, Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">DOES HEREBY CERTIFY: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. The
name of the corporation is MacroGenics, Inc. (the &#147;Corporation&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. That an Amended and Restated Certificate of Incorporation
was filed with the Secretary of State of Delaware on October&nbsp;16, 2013 (the &#147;Restated Certificate&#148;) and that said Restated Certificate requires correction as permitted by Section&nbsp;103 of the General Corporation Law of the State of
Delaware. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. The inaccuracy or defect of the Restated Certificate to be corrected pertains to the stated par value of the authorized
shares of Common Stock and Preferred Stock, which were incorrect due to a clerical error. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. With respect to the foregoing inaccuracies
and defects, the Restated Certificate is hereby corrected in the following manner: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The first sentence of Article FOURTH of the Restated
Certificate is hereby deleted in its entirety and replaced with the following: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;FOURTH: The total number of shares of all classes of
stock which the Corporation shall have authority to issue is 130,000,000 shares, consisting of (i)&nbsp;125,000,000 shares of Common Stock, $0.01 par value per share (&#147;Common Stock&#148;), and (ii)&nbsp;5,000,000 shares of Preferred Stock,
$0.01 par value per share (&#147;Preferred Stock&#148;).&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Corporation has caused this Certificate of
Correction to be executed on October&nbsp;17, 2013. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MACROGENICS, INC.</P></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Scott Koenig</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">Scott Koenig</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">President and Chief Executive Officer</TD></TR>
</TABLE></DIV>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>d613759dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P>&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g613759g92s31.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>MacroGenics Announces Closing of Initial Public
Offering and Full-Exercise of Over-Allotment Option </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ROCKVILLE, Md., October&nbsp;16, 2013 &#150; MacroGenics, Inc. (NASDAQ: MGNX)&nbsp;today announced
the closing of its initial public offering of 5,750,000 shares of its common stock, including 750,000 shares of common stock issued upon the exercise in full by the underwriters of their option to purchase additional shares to cover over-allotments,
at a public offering price of $16.00 per share, before underwriting discounts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BofA Merrill Lynch and Leerink Swann acted as joint book-running managers
for the offering. Stifel Nicolaus acted as Lead Manager and Lazard Capital Markets and Wedbush Securities Inc. acted as co-managers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A registration
statement relating to these securities was declared effective by the Securities and Exchange Commission on October&nbsp;9, 2013. Copies of the final prospectus relating to the offering may be obtained from BofA Merrill Lynch, 222 Broadway, New York,
NY 10038, Attn: Prospectus Department, or via email, at <U>dg.prospectus_requests@baml.com</U>, or from Leerink Swann LLC, Attention: Syndicate Department, One Federal Street, 37th Floor, Boston, MA, 02110, or by phone at 1-800-808-7525, ext. 4814,
or by email at <U>Syndicate@leerink.com</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall
there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful, prior to registration or qualification under the securities laws of any such state or jurisdiction. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About MacroGenics, Inc. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MacroGenics is a clinical-stage
biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases. The company generates its pipeline of product candidates from its proprietary
suite of next-generation antibody technology platforms, which it believes improve the performance of monoclonal antibodies and antibody-derived molecules. The company creates both differentiated molecules that are directed to novel cancer targets,
as well as &#147;bio-betters,&#148; which are drugs designed to improve upon marketed medicines. The combination of MacroGenics&#146; technology platforms and antibody engineering expertise has allowed the company to generate promising product
candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies. <U>www.macrogenics.com</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">### </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g613759g92s31.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Contacts: </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Scott Koenig, M.D., Ph.D., President and CEO </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">or Jim Karrels,
Vice President, CFO </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">both of MacroGenics, Inc., +1-301-251-5172, <U>info@macrogenics.com</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Karen Sharma, Director </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MacDougall Biomedical Communications
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1-781-235-3060, <U>ksharma@macbiocom.com </U> </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g613759g92s31.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g613759g92s31.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`3@"$`P$1``(1`0,1`?_$`*\``0`"`@,!`0$`````
M```````'"`$&!`4)`@,*`0$``@,!`0$`````````````!@<!`@4#!`@0```&
M`@$#`@4!!0(/``````$"`P0%!@`'$1(3""$4,2(5%A=!46&Q0B,R"8%B,R0T
M5+0E=;4V=A@X&1$``0(%`P(%`@,$!PD``````0(#`!$$!08A$@<Q$T$B,A0(
M8151(Q9Q4C,D@4*RLS1T&)&AT35U)C8W./_:``P#`0`"$0,1`#\`_OXQ"&(0
MQ"`CQZC\/U']`#]HXA$1ZRV_"[7E+ZC5XV24KE(L!*PA<5>Q]#M4N@@*DVG7
MS$4,NX;P;D2HJK"`)J'-\@B`#FRDE/JZPB7,UA#$(8A#$(8A#$(8A#$(8A#$
M(8A#$(8A#$(8A%1=^W6Q72R1_C3JQ^JRM]M8ED-CVMIR8-;ZW4,!'[L5"#TI
M6&QIF]LQ3,(&`J@G].2&#=$AYC"+'T>E5S753@Z54X].,K]>8),(]JGP)A(3
MDRKAPIP!EWCQ<QE5E!^914YC#ZCFI)49F$;7F(0Q".,=T1)<B*P=OO#TH*"/
M*:I^.12ZN`Z%N`Y`H_V@^'/J&(1R<0AB$,0AB$,0AB$,0AB$,0B`=C;K6U5L
M.GQ-R@"L=77-`D0WV41V8[6!O2KM4K.$LK84@2BXN4:`3V[LRG2*XF*;@"B.
M;!)5TZPB?0$#`!BB`@(`("`\@(#Z@("'H("&:PB%MZ[>0U%3R/V4>>PW:ROT
M:SKRH-N3O;-;)#^FQ;$23_J^P9B8%G:H!PFB7U$!,7G*1N/TA'`T%J)SK&N2
M$G:7Q;!M.^O_`+FV7:3<'/(3K@HBG%L3?!&#KZ1_;M$B\$`I1,`!U<!E2I_L
M$(GG-80Q"&(1QG;5%ZW5;+@(IJEX$2B)3D,`@8BB9P]2*IG`#%,'J`ASB$='
M!2JJR[^$D3@,O#F3!4W`%]\Q7`19229?V+$#I4`/0JI1#]F(1LN(0Q"&(0Q"
M&(0Q"&(0Q"-:M]1KM\K4S4;7&-YFOSS%5A)1[DO4FL@J'H8@_P!I%PB<`.FH
M40.FH4#%$!`!S*24JW#K"<4^INRG_C!*JZ@WE/+.*$VCI&2T_MB4$YRR=>B&
MYW2]%L[@H&Z;5`LR`1L(^KQ$"@7DPD+FQ&_S)T,([_1U:G-LW-;R=V+'KL`?
M,G$5I"G2!1ZZ=17)AZK*[;F^5.S6]+A0Y^.I)L8"@/28.DLI2`@2F8Q]8N/F
MD9AB$,0AB$,0B*M@O?MB7J-R*/0W3E4:U-B`\%/%S9^V@HI^G2S?`4X"/PY_
M?F0)Z>,(E0?W?PS4S\(QXP`><#IK&8SF80Q"&(0Q"&(0Q"*\>5=FGZ?H>_6"
ML2SR$FF#..%G)L%`2>->_+L6ZQD%1*;MG.BH8O4`<@`CQE`?*');[B'!E^R'
M&ZIZCO5/3H+;S1DM!+B`2D^!*21/PG%I<*V:UY!R=:;1>6$5%M>?(6VO5*QL
M49$>.HG%9?'69':,==]/>1GM]@GKJ-4V;!.+:0CLZM?E(QE,-W97!@35$D:=
MRD;GD?D6.0PB3D,I;XE\J9A45%]X]Y2N+M;?K:PS<6*EX^==!4LH<FH]2$!2
M5>,@OZ18'.>&8\W36O,,&I$TUHK'7J-UEL:)JZ=U2-$CT]R2@!X[)^,1U0=S
M;4M?D1KR<+;9IEK'8=YMT75ZBF<J,*>I5ELJP:G!D"94Q(LJ`&Y#Y@43$><I
M/!>9N5<O^15BOB[O6(XTR.]5[5)0S'8524:5-H44RUWKD=W[PG%B9/Q_@U@X
MCNEM10,'-K1;Z)RIJ2"7`_4K2I2`?#:G0CZRBR.^O+573M[1J$53ONMK$Q$9
M.WF2^H*M1KD?+2B+!KTII-7!3J'37(<!.8H"94A?UYS]%<Z_+!7#^;IQ*W65
M5VIJ6D9J;B^'>W[1I]Y+2--B@2=R3J4CS`2BJ^,^#/U_C1OU7<10//U#C%&T
M6POW#C3:G%ZE:2$B1!D#+:3$D[I\A875-9J<K&Q;JYS^P%VS6BUV-6*@>:4>
M(ME4G*S@2+"BT*#Q$`Z2&,H=4I2AZB(6+S%\@['Q9C-JNM#1NWB]W]:$6VE9
M4$J?+B4J2HJ(5)$EHZ)45%0`'4B'\>\5W/-[O74=2^B@MEJ0I=8^X)AD)*@1
ML$MR_*K30`))/A/4!WEN.JT?8=KVCIAO65J?6$+)$'C[0C(P\X99XFT/#KND
M4EUH^1:=T%#AP8!+Z``<9%7^;^6<4PC(,MY)PU-M5:+:FK8#5:EYJIW.)0IA
M2TH):=1N"B#NT!$A'<9XWPB^Y+:K%AF1&M37U:F'-](IIQF2"L.A"ER<09%.
MA$C&F0GES<6S[5ZVP]2!7*IMURT9U2R0]I;S)^X^4;(MU7<4+1)PF0%'B0G*
M)B'*0W4`&XXR&6/Y:96Q5XQ4<@8G]MQ3+7$(H:MBM14F;A2$%QH-I4!YT3!*
M2`9B?2)!<^#+&[3WIK%+\*Z^V%M2ZFG<IELB2-V_:Z5*23Y3+3:3I,=8VJR^
M1EZE]BV;6>CM:([`E:.`$N$W-SJ4!!,'AA.08UHH8O4LY*J0R8&,H'6H0X%+
MP439+,A^1.97;D.Y<;\+XT,@N5DTKZE^I12T[3FH[*"0=ZY@IF5)\R5`)($X
MXEIXGQ^AQ*CS'D:\FU45SG[1II@U#JT)$RXI*2-J2"F6AT(),S*-2D?(FO[%
MTGNYU>Z])4>Q:9CUY:\U<71'#@/M\YY)-.'?=M(Q32CF+49@8Y.4%#@;YRB4
M1[7&'R2H<WQS(:B_VU^T9IBP7]PH%J"Y%*5%):<D)I64%&H!2=1,$&/FR?AF
MNLV066@LU:S<+#?G&TTE4E)2#O4@*"T$F12%A4@2".LC,"EVK:_OGR8UW'>1
MN]/-&Q^-U7OLB_\`Q?2:5,PE2A6,0R<N6C0SIY+O6)9-PJ+$PD3,*KA9(G=4
M4`3])87C-'G/)-B;Y'S7+ZC'K;<'%&CIZ5:&6DM@E*=Y<("E:'3U*EN*M8M7
M)JS!^.KXOCW"\28R"Y4#8%7453;C[JG"D*5L2VDE($QK/:DG:$Z3-A[KY#WO
MP]\6(&YSE]@/+F:=;4"D0]T:2S&%2D828-(KQ99A_#$FFKB<B"QXH+B4QNLQ
MP$QO3)[>.0;SQ+QBQ>*ZM9RFL-Q%.V^'`V%MN$[=ZD!8*T2DHS\09Q!+-@EI
MY8Y+>L]!1.XQ2?;U5"V"A3FU;<MVQ*RV0A>X%(EI*4HDY/R,\C*AJW<NT=T^
M.\%0H_7%!6N%9;1FSXZSC;7K9-=9U%.A8,#'ATD4")G[QB'YZQ`"\ADG;Y"S
MZV8Q=<ER_'VJ"GH*+OM)16H?[RNNPE"9H$C,DC^B(XK`\%N>2VO',2O[M=45
MU8&'2NB<8[*3IO`6N3FO@"-/&(BU-_>0I;+\?]^;0=:[0KNP]&P7W([UVYGU
ME6\W!/V23J"ET),\>@[19NU!435$&Y^@0(8!$%"\1#%?D4UDF!WS*5V_V]\L
MK`>52*=GW&E)!0M*]H(!)(,DF7E_>$2W)_C[48]G=DQA%Q%19+R[VDU:6I=M
MU*B'$*1O()2)$36)S5TVDQ(CSS7E6M^\,J8%`8'1\JJFULLD_&><`I3CNHAI
M(E:,4?I_3+%(HY$HF4,B(@'PYR1.<S/(OF)6?V"=N34P=4KN&;$P"`!M\_J`
MF=L1YGB%IVRY7=37*"L:?[83VOX_F4F95O\`)Z9R&Z-5M'F_M>X[@OVH_%+0
MB6Y5=2N#,]AVVP7!K48!"434507A8111(Q7+LCIJLB0ZBO*JJ1^E/H)UCSKC
MS1DEVRZOQ/C"QB\+M1":I]RH2PTE>LVT%0.Y4P4SGJH'RR$XZ-!P[C]IQ.@R
MKDB^?:$W0%5*RBF74.*;\%K"2-HD02"-`1-4S(9OWF_M5G>M2:1U[H5H;?&Q
M:"CL"?I^R;VSJT/2TC>_`]:-,)-3A-3AAC%C%[8)EZ.C@IS&,!,7[FK)*:]6
MO#;'9$*SBX4'N7*>JJ4L-TX$_P`HN%/YCAD9`2\)3U`6/AVPU%DN>8WJ]E&%
MT-;[=JHIZ93ZW^GYA;2J;38!$RJ>LQH)$VG_`"/NW\$_?'X+6_-':]K^'_O*
M(]K]6^L_2>]]W]/L/H7MO\^[O1W/;_+QU>N6;^H<R_1'WG[(?U?ME[#OHEOW
M[/\`$>G9M\^[\(KC[!B/ZR^S?>?^T]T_?]AR>SM[_P##SW[I_E[9^J.#Y>Q<
MI->/>PXV'CGTM(.&49V(^-:+/7JXIS4>H?LMVY%%U!(F03#TE'@`$<J_Y:6J
MZ7O@#(;996'JJY.TZ`AII"G'%?FH)"4)!4K3\-8D?!==0VWE:SUMR>;IZ)#Z
MMSCB@A"1VUZJ4>D4OWUK[9-?A-*WK7,%.'L%FTU':CN32-BWCEXW(\KC!HD$
MFW03%5DIV72J/<.!>R=`O/`AGX[^0&`<EV.WXCGG&]%6_?KEC#=BN"6FEJ<;
M0XPE"5.H2`4$)6I.]7H+:0=0(OOB7*,,N3]_QC,WZ;[727M5SI%..(2E2FWE
M*4$*5HH$I20A.JTK4?$Q)TUJV2HFV?#F"B(24>PE#K\RVG95A'.G+!H]!BJY
MDG#URW2.@W4>/E%#EZQ`3B;@.<LB[\87/!>5N([-:**H>LUBMCS=4ZTTM:&W
M`V5.*<6@2!<65$%7J,HAU'FM'DV#9]<J^I81<[I64ZV6EK"5K27I)2A),R$(
MV@_N@$Q&,)J7?FY$-X7IFUJU=C=N2CZ%<Q&P(>:1LYX"O..]!)PX%0($8D4R
M:(%.H`@=9$#<<%#*SM'$_//+K><9M2,6JWV[+:EVF6S=&7TUGM:18]L*=.PA
MI)VI4@GJL!7@(FEQSCC#`G<8QUURNJJRPM(>#U"XT:?OU"07NX9DKEJ%;9>4
MR\8UI*$VU*:TT-L$*+9I2?\`'2YR$%/UIS%OT):3KS)[%2T/*QS9PAWGR"31
M'VAU$BGZ!3*;@0`<B[=AY9K^-<%Y`58KE5Y#Q]=G:2KHEM+#SU(VXAUE]E*D
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MJ!K3RAVMM^%E:!`>13MKKROQ<@B<LQ%,[*NY:MK&_C@(#DZ<48Z3@R8%!1<C
M=;I#@2\R3@GB_+\UKN0N1\JH*BR-YH%M4E-4)"'TM@+(><0?,F1*0D*`*B%&
M6V1/Q9_GEBQ)>'8WC]6U<W<84AVH>:)+2W"I&YIM7B-#YO`$"<P0*V5:Z*:W
MT1&^+/EYX>['V8^U@$\EJ>TU>DK76JRQ)(D@,')LWB!D$FRC<)$2$<$.H)FX
ME`Z9%"F`?6VWA6,X2CBSEO$+E<'K5W$4;K-/[AER>X-K200$D%7J!5I([01$
MZN=J3D>:N<F\3Y9;[<S=$MJK&W:CL/-D!/<24R)(.V920G6<E*!$:!-:3VW&
M_P!UW0Z=(:MOB=G_`/)(UH<51M6916RHUEV2:`DJ>';-SR#5LN4X=!SD(("8
MHCQR&1RMPG+*?XS4=E=MMP%S&0A[M):47@R23OV)\R0H3`T$B1'>I<SQ2I^2
M=5>V[E1*M7V`L]XN(#)>\@"-ZM"4^/68!ZQ:&NL-://%CR^HFCM.^3]8EYG4
MZTB^;;DB[C(J6"1*Q?QK&.IXS<G++KO2=:@JMVI""<HE,(#P`!:-MI\><XQR
MBQ89:<DIJIZVA:Q<$ON%U8&T(8[KCA*NNY*0GP,M(K:XU5^1R5C%\RZ[8W44
MS-Q*$JH"PWVT$A16^&VV_+H`%*)\1/6*U^0F@=N4#4&E=O:NH=IE7>U_&.(T
M1O2F14!+.I=!P%99#"SDI#-&QWR#I(&::2ASI<IKLDP-P*@Y6.?8#EMBP^S9
M3B]!5N5%TQQJW7&G:;67`I+:2VXI`$PH`;5`B6Y"9Q8^"YUB=\RV\8QE%?3H
M8MF1.W*W5*EH2VH%Q25MI4HR*23N3(RVK5X18R8U[?@W9_=3._LJV&:4S6L8
MSM[LM?DS-:L[1KD:FLVL3@K84H9=,X"42.#)FZ@$..<L>IQ^_G,>,GA1U09I
M*$"H/;5^20E,PZ?ZFO@J*ZH[]83B/)+:JRE[]77$L)[B9O`K7JT/Z^G[L==J
M6TWKP$WSY*0>P]*[6O=!W#>%[S1;SK&J.;85Z9=[,/&T:[3;F(1%4R,R"2I3
MJ%4071,(D$B@&#YL5N5\X*SG(J._V:Z5]CNM7[BEJ*1DNA4U*5L5J!KOEJK<
ME0(VD$&/JRBW63F_",?KK+>+707RUTGMJJGJWNR0`$C>F8),BB<PG:4D>8$$
M1L/F!8=0;DBZG);F\7/)NK[!>:VC[)K.^Z\JSR3L,%,3(R"Z-'GWT,<J3-]#
M2"""KAN\25*G[D12,F83"/4Y<KL2R^FI:C+,;R*GOBJ%+M'54K14ZVXO<4T[
MBD$;5(4`5(6"!NTCF\4T64XG4U#&+9%CM18TUZFJREJG@EIUMO8#4(2L'<E:
M20A:#,[>AC/T3SM_^9GTWNWC\W_7.Y[7W!ORA^'/><?3>]U?5?N+V7\G5[_V
M7R<]?IGE['F__3?[7^=_6?N.F[^<^W[O3/U]W9X?Q-GA./?WG"G^H7W,J+]&
M]GKM_D_?R]4O1V=VN[^'OUE*/3GR.L$W5-(;)L=<DG$/-Q-;6<QTFTZ`<M''
MN$$P51%0BA"J%*<>!$H\<Y<?R'O]ZQ7A/),CQVH72WRCMJW&742W-K!2`I,Y
MB>OB#^R*&XIM5OOG(]GM-U:2_;JBL2AQM4]JDD'0R(,M/Q'[8E6N.%G=>@G;
ME057#J'C'+A4W`"JNNR0564$"\``G4.(^GIZY9V.U#U7C]#55"BNH=HV5J4>
MJE*;25$_4DDF(;=6FV+I4L,C:RBH<2D?@`L@#^@1W.=B/@AB$,0AB$,0AB$>
M;/E&_-NKR)TCXVPYC.8Z!F6^QMD"ER=)JR9D*Z:,W8>A`.$2FJ/`_P`SU(/B
M(9[MC:V5&$>DH````````````!P``'H```>@``9X0C.(0Q"&(0Q"&(0Q"&(1
M7ORN_P#77;7_`&JM_M;3*!^4W_SSEO\`TAS^TB+2X2_]L6'_`#Z/[*HF2I_]
M+5K_`(!#_P#+F^6_BO\`XO;?\A3_`-RB(!>_^<UG^:=_O%1L&=^.9#$(8A#$
M(8A$">0^^ZSH&B.K)+'3?6&0!5A3JP0X^]L$V8G"*14B<K%CVASE.Y5`."$X
M*'SG(4=D)WGZ"$0_X=Z5LM5C[+N?:A5%MO;><FF)4KLO#FOP3E7W;*'$AO\`
M17+D1(JND'^1*1)'T%(<W<6#)"?2(1=O/*$,0AB$,0AB$,0AB$,0B#/):'EK
M!HC9T+!1SR7EY"LKI,8V/0,X>.U0<MC]IN@3DZJ@D((@4/4>,I3Y&V:ZY#P=
MDUDL=.[57>IM:T-,MI*EN**DR2E(ZGZ18W$=QH+3R79;C<W4,4+-:E2UK,DI
M3(B9/@-8EBM(JMJY`-G"9DEV\+%H+I'#@Z2R3%!-5,X?H8ARB`_O#+1QMEVF
MQV@IWTE#[=$PE23U2I+200?J""#$)NSK;UUJGFB%-+J'2".A!6H@CZ$1W)C%
M(4QSF*0A0$QC&$"E*4`Y$QC#P```?$<[4<^,E,4Y0,4P&*8`,4Q1`2F`0Y`0
M$.0$!#$(SB$?BNX0:HJ.'*R3=NB05%EUU"(HI)E]3**JJ&*1,A0^(B(`&(13
MS9?F+48>05H^F8IYO#:3@YVS2`IY%'T%&./4GN)^P-@,S2:H'$!,5$YQ$.0,
M=(/F#T2W/51`$(UW4'C%:YN[([U\FY=M;]E@*:]:J#8Q5JGK]$IA5;(-D`$S
M5V_9F-R0"=2"*G)^I94>X&5+$MJ/3"+UYY0AB$,0AB$,0AB$,0AB$,0CY'CG
MU']`_B/&:G9K.4_]\#TUZ1D../3]_P#',CI"/E7M]M3O='9Z#]WN]/;[?2/7
MW.KY>CIYYY].,S"(-DF.O9!ZLA7IF]0;X3CWGNM4KFM%E4Z@Y[Y(F*F*AW`-
M\>XD(_'G]<V,_&$=5)ZXMR[<QD/(+=;%F)?1)M5J2X?`3@>`!0NL#2(J`'[N
MK_#F00/`0BLMZJ7C="N4C[_VCY%V]N!P_I;&B]PL:>;@?YRUVA0,`"0C\>I7
MHXSU"EGT!(_V?\81;[2WX*^VT_P5]A_;W03N?9?T[J_Q?J?M_P#>'?Y_UG^I
>SGBK=/S=81,V:PAB$,0AB$,0AB$,0AB$,0AB$?_9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
